These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 604189)

  • 21. [Changes of bile acid metabolism in hepatic coma and precoma].
    Erb W; Haase A; Walczak M; Leuschner U
    Verh Dtsch Ges Inn Med; 1972; 78():1401-2. PubMed ID: 4665559
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of serial resin hemoperfusion in fulminant hepatic failure.
    Bihari D; Hughes RD; Gimson AE; Langley PG; Ede RJ; Eder G; Williams R
    Int J Artif Organs; 1983 Nov; 6(6):299-302. PubMed ID: 6668092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain proteins in hepatic encephalopathy.
    Brun A; Dawiskiba S; Hindfelt B; Olsson JE
    Acta Neurol Scand; 1977 Mar; 55(3):213-25. PubMed ID: 848274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of [14C]cholic acid in fulminant hepatic failure: a prognostic test.
    Horak W; Waldram R; Murray-Lyon IM; Schuster E; Williams R
    Gastroenterology; 1976 Nov; 71(5):809-13. PubMed ID: 964572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.
    Leifeld L; Trautwein C; Dumoulin FL; Manns MP; Sauerbruch T; Spengler U
    Am J Pathol; 1999 Jun; 154(6):1711-20. PubMed ID: 10362796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan and hepatic coma.
    Ono J; Hutson DG; Dombro RS; Levi JU; Livingstone A; Zeppa R
    Gastroenterology; 1978 Feb; 74(2 Pt 1):196-200. PubMed ID: 620892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical value of the determination of primary bile acids in serum and urine in liver diseases].
    Song YG; Fan SL; Li ZJ
    Zhonghua Nei Ke Za Zhi; 1986 Oct; 25(10):604-7, 637. PubMed ID: 3568843
    [No Abstract]   [Full Text] [Related]  

  • 28. Admission levels of serum Gc-globulin: predictive value in fulminant hepatic failure.
    Schiødt FV; Bondesen S; Petersen I; Dalhoff K; Ott P; Tygstrup N
    Hepatology; 1996 Apr; 23(4):713-8. PubMed ID: 8666322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure.
    Harrison P; Wendon J; Williams R
    Hepatology; 1996 May; 23(5):1067-72. PubMed ID: 8621135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fulminant hepatic failure induced oxidative stress in nonsynaptic mitochondria of cerebral cortex in rats.
    Reddy PV; Murthy ChR; Reddanna P
    Neurosci Lett; 2004 Sep; 368(1):15-20. PubMed ID: 15342125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis G virus infection in fulminant hepatic failure.
    Sáiz JC; Sans M; Mas A; Olmedo E; Forns X; López-Labrador FX; Restrepo JC; Costa J; Salmerón JM; Guilera M; Ampurdanés S; Sánchez-Tapias JM; Jiménez de Anta MT; Rodés J
    Gut; 1997 Nov; 41(5):696-9. PubMed ID: 9414981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in plasma and CSF levels of GABA, 5-HT and amino acids in fulminant hepatic failure.
    Singh NK; Thapliyal A; Jain AK; Chansuria JP; Gupta JP; Srivastava PK
    Indian J Gastroenterol; 1985 Oct; 4(4):253-5. PubMed ID: 3850849
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat.
    Chang CC; Wang SS; Huang HC; Chan CY; Lee FY; Lin HC; Nong JY; Chuang CL; Lee SD
    Eur J Pharmacol; 2011 Sep; 666(1-3):226-32. PubMed ID: 21575628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical value of serum concentration of total bile acids in chronic hepatopathies].
    Pazzi P; Arlotti A; Stabellini G; Trevisani L; Sartori S; Faggioli M
    Minerva Med; 1985 Jan; 76(3-4):105-12. PubMed ID: 3974919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum osteopontin levels in patients with acute liver dysfunction.
    Arai M; Yokosuka O; Kanda T; Fukai K; Imazeki F; Muramatsu M; Seki N; Miyazaki M; Ochiai T; Hirasawa H; Saisho H
    Scand J Gastroenterol; 2006 Jan; 41(1):102-10. PubMed ID: 16373283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of fulminant hepatic failure by scintigraphy with technetium-99m-GSA.
    Shiomi S; Kuroki T; Kuriyama M; Takeda T; Nishiguchi S; Nakajima S; Tanaka T; Ochi H
    J Nucl Med; 1997 Jan; 38(1):79-82. PubMed ID: 8998156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for fulminant hepatic failure in the United States: October 1987 through December 1991.
    Detre K; Belle S; Beringer K; Daily OP
    Clin Transplant; 1994 Jun; 8(3 Pt 1):274-80. PubMed ID: 8061367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems.
    Dixit V; Chang TM
    ASAIO Trans; 1990; 36(1):21-7. PubMed ID: 2306387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure.
    Paschoal FM; Nogueira RC; Oliveira ML; Paschoal EHA; Teixeira MJ; D'Albuquerque LAC; Bor-Seng-Shu E
    Arq Neuropsiquiatr; 2017 Jul; 75(7):470-476. PubMed ID: 28746435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.